Latest fiscal year 2025 · computed deterministically from XBRL 10-K data · coverage 100%
In fiscal 2025, GILEAD SCIENCES, INC. reported revenue of $29.44B, up 2.4% year over year. Operating margin was 34.0% and net margin 28.9%, on a free-cash-flow margin of 32.1% with capital expenditure at 1.9% of revenue. Every figure is computed directly from GILD's SEC XBRL 10-K filing — deterministic, with no estimates.
| Fiscal year | Revenue | Op margin | Net margin |
|---|---|---|---|
| FY2025 | $29.44B | 34.0% | 28.9% |
| FY2024 | $28.75B | 5.8% | 1.7% |
| FY2023 | $27.12B | 28.0% | 20.9% |
| FY2022 | $27.28B | 26.9% | 16.8% |
| FY2021 | $27.30B | 36.3% | 22.8% |
How does GILD compare against its actual peer set?
A CompsDesk subscription covers unlimited benchmark packs on any covered company: up to 19 metrics (6 core guaranteed) × up to 5 fiscal years × up to 12 chosen peers, percentile placement, the subject's figures cited to their SEC tag, form and period with every company identified by its CIK, PDF-ready HTML + CSV, generated on demand.
Related in the same sector: AAWH · ABBV · ABCL · ABT · ABUS · ACAD
Source: SEC EDGAR XBRL (10-K filings), latest filed values. "n/a" = not disclosed under mapped tags — never estimated. Informational benchmarking, not investment advice. © CompsDesk / Sam Arora.